Lithium Bis(trimethylsilyl)amide

Biographical Sketches

Yong-Hui Liu was born in 1986 at Langfang, Hebei Province, P. R. of China. He graduated from the Xuchang University in 2009 and received his B.Sc. degree in Chemistry. Presently he is working as a postgraduate towards his M.Sc. under the supervision of Professor Zhan-Hui Zhang at the Hebei Normal University. His research interest is focused on the development of new synthetic methodologies of heterocyclic compounds.

Introduction

Lithium bis(trimethylsilyl)amide (LiHMDS) is a colorless solid, which is soluble in a variety of organic solvents suitable for reactive compounds, such as organometallic substances or substituted metal amides. The compound melts at 71-72 ˚C. [¹] It is unstable in air and catches fire when compressed, but it is stable in an atmosphere of nitrogen. Reactions with a variety of nonmetallic halides give lithium halides and hexamethyldisilazyl derivatives. The preparation of lithium bis(trimethylsilyl)amid must be performed in an atmosphere of dry nitrogen. The pentane containing n-butyllithium is added slowly to a stirred solution of hexamethyldisilazane (Scheme [¹] ). The reaction mixture is boiled for 30 minutes, and evaporate the solvents. LiHMDS is obtained as colorless crystals.

Scheme 1

Abstracts

(A) B. Li et al. [²] reported an efficient and catalyst-free procedure for the synthesis of 2-[4-(4-cyanophenoxy)phenyl]-1H-indole-6-carboximidamide hydrochloride salt from 2-[4-(4-cyanophenoxy)phenyl] indole-6-carbonitrile by treatment with LiHMDS using THF as solvent at room temperature.
(B) A new method for preparing 2-lithio-(4S)-isopropyl-2-oxazolide from (4S)-isopropyloxazoline in THF using LiHMDS was developed. The product is isolated by deprotonation of (4S)-isopropyl­oxazoline with LiHMDS followed by removal of the volatile materials. [³]
(C) Petersen and co-workers [4] reported that 1 was treated with ­LiHMDS in THF at room temperature to produce 2 in a yield of >90%. Under same conditions, only lower yield of 2 was obtained using pyridine, DBU, acetylide or KOt-Bu.
(D) The preparation of the regioisomeric 3-amino-5-substituted-1,2,4-thiadiazoles can be attained by treatment of the 3-bromo-5-substituted-1,2,4-thiadiazoles with LiHMDS in THF. [5]
(E) LiHMDS has been employed in the preparation of enone 3 in two steps via deprotonating the acetate and NHCbz groups to induce a Dieckmann cyclization, followed by methylation with K2CO3/Me2SO4. [6]
(F) Ruediger et al. found that treatment of protected epoxide 4 with LiHMDS in THF at reflux temperature formed the allylic alcohol 5 exclusively. However, when 4 was treated with lithium di-n-propyl­amide the unexpected allylic alcohol 6 was obtained. [7]
(G) Lee et al. reported that 7 underwent cyclization by treatment with LiHMDS in THF to give 8. [8]
(H) A series of β-nitroalcohols can be converted into the corresponding nitroimines by the retro-nitroaldol-nitro-Mannich sequence of β-nitroalcohols with LiHMDS. In this reaction, LiHMDS behaved not only as base, but also as  reagent. [9]
(I) LiHMDS behaved as a sterically hindered non-nucleophilic base in Pd/proazaphosphatrane ancillary ligand P(i-BuNCH2CH2)3N-­catalyzed aminations of arylhalide. [¹0]
(J) In addition to the above cases, LiHMDS can also be applied for the preparation of the bis(ethylene) complex (pypyrH)RhCl(C2H4)2 by the treatment of (pypyrH)-RhCl(C2H4)2 in benzene at ambient temperature. [¹¹]

References

• 1 Amonoo-Neizer EH. Shaw RA. Skovlin DO. Smith BC. Inorg. Synth.  1966,  8:  19 
• 2 Li B. Pai R. Cardinale SC. Butler MM. Peet NP. Moir DT. Bavari S. Bowlin TL. J. Med. Chem.  2010,  53:  2264 
• 3 Baird B. Pawlikowski AV. Su J. Wiench JW. Pruski M. Sadow AD. Inorg. Chem.  2008,  47:  10208 
• 4 Petersen MÅ. Broman SL. Kadziola A. Kilså K. Nielsen MB. Eur. J. Org. Chem.  2009,  2733 
• 5 Wehn PM. Harrington PE. Eksterowicz JE. Org. Lett.  2009,  11:  5666 
• 6 Pragani R. Stallforth P. Seeberger PH. Org. Lett.  2010,  12:  1624 
• 7 Ruediger E. Martel A. Meanwell N. Solomon C. Turmel B. Tetrahedron Lett.  2004,  45:  739 
• 8 Lee C. Lee JM. Lee NR. Kima DE. Jeong YJ. Chong Y. Bioorg. Med. Chem. Lett.  2009,  19:  4538 
• 9 Tanaka S. Kochi K. Ito H. Mukawa J. Kishikawa K. Yamamoto M. Kohmoto S. Synth. Commun.  2009,  39:  868 
• 10 Urgaonkar S. Verkade JG. Adv. Synth. Catal.  2004,  346:  611 
• 11 McBee JL. Escalada J. Tilley TD. J. Am. Chem. Soc.  2009,  131:  12703